BUZZ-Valeant Pharmaceuticals International Inc: Appoints interim CEO

Wed Jan 6, 2016 8:50am EST
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

** Canadian drugmaker's U.S.-listed shares down 3 pct at $97.90 premarket

** Company appoints Howard Schiller interim chief executive, effective immediately

** Schiller steps in for Michael Pearson, who remains hospitalized with severe bout of pneumonia

** Valeant also appoints Robert Ingram interim chairman

** Company says timing of Pearson's return is uncertain and he will be on medical leave until further notice

** Up to Tuesday's close, stock had fallen about 11 pct since Dec. 24, last trading day before company announced its interim management team